Dec 18, 2019
Trump Administration takes historic steps to lower U.S. prescription drug prices
Sep 13, 2019
HHS Office of Inspector General Report Shows Rebates Reduced Medicare Part D Drug Spending
Jul 16, 2019
New Survey Shows Older Adults Are Willing to Pay More in Monthly Medicare Premiums to Ensure a Cap on Out-Of-Pocket Prescription Drug Costs
Jun 18, 2019
Statement from Acting FDA Commissioner Ned Sharpless, M.D., on a new effort to improve transparency and predictability for generic drug applicants to help increase timely access to high-quality, lower cost generic drugs
Apr 04, 2019
Supporting greater availability of lower-cost generic drugs for Canadians
Mar 06, 2019
PCMA Statement on Prescription Drug Rebate Legislation
Dec 03, 2018
Report: Canadian R&D-to-Sales Ratio for Brand-Name Drug Companies Less than Half of 10% Commitment
Aug 15, 2018
New Data: Rebates are Unrelated to Drugmakers' Pricing Strategies
Jun 26, 2018
High-cost specialty drugs continue to dominate the new drug landscape
May 17, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
Feb 20, 2018
Prime Therapeutics Proves PBMs' Value: Delivers Negative Drug Trend in 2017
Feb 06, 2018
Canadian generic drug prices higher than international levels in recent years
Dec 12, 2017
Canadian Health Policy Institute: Adjusting for population and inflation, the total direct cost of patented drugs has experienced near zero real growth for the last decade